WIT has designed an electronic wireless device that will monitor the bloodstream for a recurrence of the defective proteins that mark particular malignancies as they grow.
The I3C is a patented non-invasive method designed to monitor the blood antigen levels of cancer patients via protein antigen
markers in the blood. This process can monitor Alzheimer’s and 8 other cancer antigens: colorectal,
ovarian, uterus, cervix, esophageal, fallopian, gastrointestinal, certain variations of breast and lung, and prostate.
Ready to Ask For Funding for your company?
Post a Funding Request